Trial
NCT03825289
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
Novartis Pharmaceuticals; Huntsman Cancer Institute
Condition
Metastatic Pancreatic Carcinoma
Intervention
Hydroxychloroquine
Why stopped
Lack of Funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-14